CAGE PHARMA Trademark

Trademark Overview

On Monday, April 9, 2018, a trademark application was filed for CAGE PHARMA with the United States Patent and Trademark Office. The USPTO has given the CAGE PHARMA trademark a serial number of 87868196. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 13, 2021. This trademark is owned by Cage Pharmaceuticals, Inc.. The CAGE PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the prevention and treatment of cancer
cage pharma

General Information

Serial Number87868196
Word MarkCAGE PHARMA
Filing DateMonday, April 9, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 11, 2018

Trademark Statements

Disclaimer with Predetermined Text"PHARMA"
Goods and ServicesPharmaceuticals for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 17, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCage Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21201
Party NameCage Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBaltimore, MD 21201

Trademark Events

Event DateEvent Description
Monday, December 13, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 13, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 24, 2021EXTENSION 5 GRANTED
Tuesday, March 9, 2021EXTENSION 5 FILED
Wednesday, March 24, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 9, 2021TEAS EXTENSION RECEIVED
Tuesday, January 19, 2021ASSIGNED TO EXAMINER
Thursday, September 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 22, 2020EXTENSION 4 GRANTED
Tuesday, September 22, 2020EXTENSION 4 FILED
Tuesday, September 22, 2020TEAS EXTENSION RECEIVED
Saturday, May 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 30, 2020EXTENSION 3 GRANTED
Thursday, April 30, 2020EXTENSION 3 FILED
Thursday, April 30, 2020TEAS EXTENSION RECEIVED
Saturday, October 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2019EXTENSION 2 GRANTED
Thursday, October 3, 2019EXTENSION 2 FILED
Thursday, October 3, 2019TEAS EXTENSION RECEIVED
Thursday, April 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 9, 2019EXTENSION 1 GRANTED
Tuesday, April 9, 2019EXTENSION 1 FILED
Tuesday, April 9, 2019TEAS EXTENSION RECEIVED
Tuesday, November 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 11, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 11, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 22, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 9, 2018ASSIGNED TO LIE
Friday, July 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 27, 2018EXAMINER'S AMENDMENT ENTERED
Friday, July 27, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 27, 2018EXAMINERS AMENDMENT E-MAILED
Friday, July 27, 2018EXAMINERS AMENDMENT -WRITTEN
Friday, July 27, 2018ASSIGNED TO EXAMINER
Tuesday, April 17, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 12, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharma cage cancer treatment prevention pharmaceuticals